XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisition-Related Contingent Consideration
9 Months Ended
Sep. 29, 2018
Acquisition-Related Contingent Consideration

7.    Acquisition-Related Contingent Consideration

In connection with the acquisition of Solar Implant Technologies, Inc. (“SIT”), Intevac agreed to pay to the selling shareholders in cash a revenue earnout on Intevac’s net revenue from commercial sales of certain products over a specified period up to an aggregate of $9.0 million. Intevac estimated the fair value of this contingent consideration on September 29, 2018 based on forecasted revenues reflecting Intevac’s own assumptions concerning future revenue from such products.

The fair value measurement of contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Any change in fair value of the contingent consideration subsequent to the acquisition date is recognized in income (loss) from operations within the condensed consolidated statement of operations. The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the three and nine month periods ended September 29, 2018 and September 30, 2017:

 

     Three Months Ended     Nine Months Ended  
     September 29,
2018
     September 30,
2017
    September 29,
2018
     September 30,
2017
 
     (In thousands)  

Opening balance

   $ 370      $ 859     $ 362      $ 759  

Changes in fair value

     —          (283     8        (181

Cash payments made

     —          (172     —          (174
  

 

 

    

 

 

   

 

 

    

 

 

 

Closing balance

   $ 370      $ 404     $ 370      $ 404  
  

 

 

    

 

 

   

 

 

    

 

 

 

The following table displays the balance sheet classification of the contingent consideration liability account at September 29, 2018 and at December 30, 2017:

 

     September 29,      December 30,  
     2018      2017  
     (In thousands)  

Other accrued liabilities

   $ 370      $ 103  

Other long-term liabilities

     —          259  
  

 

 

    

 

 

 

Total acquisition-related contingent consideration

   $ 370      $ 362  
  

 

 

    

 

 

 

The following table represents the quantitative range of the significant unobservable inputs used in the calculation of fair value of the contingent consideration liability as of September 29, 2018. Significant increases or decreases in any of these inputs in isolation would result in a significantly lower or higher fair value measurement.

 

     Quantitative Information about Level 3 Fair Value Measurements at September 29, 2018  
     Fair Value      Valuation Technique    Unobservable Input    Weighted Average  
     (In thousands, except for percentages)  

Revenue Earnout

   $ 370      Discounted cash flow    Weighted average cost of capital      12.1